BCB
MRNA icon

Brian C. Broderick’s Moderna MRNA Stock Holding History

Brian C. Broderick’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,000
Closed -$1M – 84
2024
Q3 		$1M Sell
15,000
-6,600
-31% -$606K 0.2% 57
2024
Q2 		$2.56M Hold
21,600
– – 0.52% 43
2024
Q1 		$2.3M Buy
21,600
+12,000
+125% +$1.21M 0.49% 39
2023
Q4 		$955K Hold
9,600
– – 0.24% 51
2023
Q3 		$992K Buy
9,600
+4,800
+100% +$535K 0.27% 49
2023
Q2 		$583K Hold
4,800
– – 0.15% 56
2023
Q1 		$737K Hold
4,800
– – 0.21% 51
2022
Q4 		$862K Buy
4,800
+2,300
+92% +$376K 0.26% 49
2022
Q3 		$296K Buy
+2,500
New +$379K 0.09% 67

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Brian C. Broderick's MRNA Position: Q4 2024 in Review

Brian C. Broderick sold out of Moderna (MRNA) in Q4 2024, closing a stake of 15,000 shares — an estimated $1M sold.

Brian C. Broderick first reported a position in MRNA in Q3 2022 and held it in 9 quarters. The position peaked at $2.56M in Q2 2024. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Brian C. Broderick reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Brian C. Broderick sold 15,000 Moderna shares in Q4 2024, an estimated $1M.
  • Brian C. Broderick first reported a position in Moderna in Q3 2022 and held it in 9 quarters.
  • Brian C. Broderick's Moderna position peaked at $2.56M in Q2 2024.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Brian C. Broderick's 13F filing for Q4 2024, filed 13 Feb 2025.